Success Stories: Securing the Future of Biomedical Research: A Dual I-140 Approval for a Promising Scientist
Client’s Testimonial:
“Thank you so much for your help throughout my EB1A petition — especially during the RFE stage. I’m very grateful that both my NIW and EB1A cases were approved!”
On March 18th, 2025, and July 2nd, 2025, we received another EB-2 NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) approvals for a Ph.D. Student in the Field of Biomedical Science (Approval Notice).
General Field: Biomedical Science
Position at the Time of Case Filing: Ph.D. Student
Country of Origin: China
State of Residence at the Time of Filing: Pennsylvania
Approval Notice Date: : February 18th, 2025 (NIW) and July 2nd, 2025 (EB1A)
Processing Time: 10 months, 5 days (NIW) / 3 months, 25 days (EB1A) (Premium Processing Requested)
Case Summary:
When it comes to biomedical science, contributions that translate into real-world clinical insights are especially valuable. One client, originally from China and currently pursuing doctoral studies, recently achieved both EB-2 NIW and EB1A petition approvals with our support at NAILG, demonstrating that even at an early career stage, extraordinary ability and national interest impact are not mutually exclusive.
A Research Portfolio Rooted in Human Impact
Specializing in the intersections of bioinformatics, cancer genomics, clinical genetics, and multi-omics, the client’s research has focused on rare pediatric blood cancers and chronic conditions like type 2 diabetes. Her work has yielded important insights into gene mutations that drive disease mechanisms. These findings have implications not only for disease understanding but also for the development of targeted therapies.
With a publication record that includes six peer-reviewed journal articles, some in top-tier outlets such as BMJ and the Journal of Hepatology, and a citation count of 776, the client’s influence has reached scholars and clinicians across more than 50 countries. Her work has not only filled critical gaps in our understanding of disease etiology but has also been incorporated into clinical reviews and national policy reports on public health and cancer strategy.
Recognition Through Service and Citation
In addition to publishing, the client has served as a peer reviewer at least 28 times for respected journals and scientific conferences, affirming her role as a trusted expert in her field.
Expert Endorsement and Letters of Support
As highlighted by one of the client’s independent recommenders:
“[Client’s] findings provide a basis for understanding how specific gene alterations drive disease development and response to therapies. It is evident that her work has established new knowledge and opened up clinical pathways for improved patient care across several high-impact conditions.”
This sentiment echoed throughout all submitted expert letters, many of which were authored by senior scholars from institutions in the United States and Europe, all affirming the originality, significance, and global relevance of the client’s scientific endeavors.Responding to USCIS with a Robust Strategy
Despite receiving a Request for Evidence (RFE) during the EB1A petition process, we at NAILG strategically leveraged the client’s peer-reviewed record, international citations, funding support, and expert testimonials to document her extraordinary ability and sustained acclaim. These efforts were met with approval, validating the strength of her case under premium processing.
A Clear Path Forward
This dual approval speaks not only to the client’s past accomplishments but also to her potential to make further advancements in U.S.-based biomedical research. As they continue exploring innovative applications of bioinformatics and genomics in the diagnosis and treatment of rare diseases, we’re proud to have helped secure a future for her work to thrive in the United States.
At NAILG, we are honored to support researchers like this client—those who combine academic excellence with meaningful societal contributions—to achieve her immigration goals and continue making an impact.